TMCI (Treace Medical) Company Projected Revenue

Brandmark of Treace Medical (TMCI)

Treace Medical Concepts (TMCI) is aggressively expanding its sales force, driving revenue growth through a high-incentive bonus system. The organization's projected sales revenue clearly demonstrates the dynamics of this process, where 0.20 serves as the current parameter value. However, it is necessary to critically assess the dependence on a narrow orthopedic segment and the effectiveness of joint research programs with physicians, despite the high authority of the company's patented systems.

TMCI - Treace Corp Company Expected Sales Volume over the range 07/04/2022 - 11/16/2026

Analytical breakdowns and data insights for company Treace Medical (TMCI)

Fundamental company analysis:treace.com
Brand item of Treace Medical Concepts Inc

This indicator reflects the dynamic correlation between the market value of shares and projected revenue, allowing for an assessment of the business's fundamental value between official reports. By analyzing the expected sales volume of Treace Medical Concepts (TMCI), an investor can see the real pace of expansion, which is driven by the development of direct sales channels and physician training without the use of acquisition strategies.

Analysis of competing companies

Company Projected Revenue Boston Scientific Corp (BSX)|EW - Company Expected Sales Volume|Projected Sales Volume RMD (resmed.com)|PODD - Company Future Sales Volume|Zimmer Biomet Holdings, Inc. - Projected Sales Volume|COO (The Cooper Companies) - Company Revenue Forecast|ALGN: Projected Sales Volume|Company Revenue Forecast GMED|TMDX (TransMedics Corp) - Projected Sales Volume|ATEC Spine (ATEC) - Company Future Sales|Projected Sales Volume AORT|Company Future Sales Volume Enovis Corporation ENOV|Projected Sales Volume IART (integralife.com)|Projected Sales Volume Establishment Labs Corp ESTA|BBNX - Company Projected Revenue|IRMD: Company Projected Revenue|EMBC (Embecta Corp.) - Company Future Sales Volume|Tandem Diabetes Care - Company Future Revenue|AXGN (Axogen Surgical) - Projected Sales Volume|Company Expected Sales Volume SI-BONE Inc SIBN|Company Projected Revenue Orthofix Medical (OFIX)|Projected Sales Volume Bioventus Corp (BVS)|OrthoPediatrics Corp - Company Future Sales Volume|Projected Sales Volume Strata Critical Medical Inc SRTA|Carlsmed, Inc. - Projected Sales Volume|Company Future Sales RxSight Inc RXST|ClearPoint Neuro (CLPT) - Company Projected Revenue|Company Expected Revenue STXS (Stereotaxis Corporation)|Company Projected Revenue neurostar.com|Company Future Sales Volume Sight Sciences, Inc. (SGHT)|Projected Sales Volume OBIO|ANIK - Company Expected Sales Volume|Company Projected Revenue InspireMD, Inc. NSPR|ZJYL: Company Revenue Forecast|VANI: Company Future Sales Volume|Xtant Medical Holdings, Inc. - Company Projected Revenue Volume|NeuroOne Corp (NMTC) - Company Projected Revenue|Company Future Sales Volume Modular Med|Company Projected Revenue myomo.com|Company Revenue Forecast COCH (Envoy Medical, Inc.)|Company Future Sales Volume VVOS (Vivos Therapeutics)|Company Projected Revenue NVNO (enVVeno Medical Corp.)|Sintx Technologies, Inc. - Company Future Sales Volume|Tenon Medical Inc. (TNON) - Company Expected Sales Volume|LFWD - Company Projected Revenue|AMIX (Autonomix Medical) - Company Revenue Forecast|IVF: Projected Sales Volume|BBLG (Bone Biologics) - Company Projected Revenue|Company Projected Revenue Axonics Inc.|Company Expected Sales Volume Biolase, Inc. BIOL|Company Projected Revenue Dynatronics Corp. (DYNT)|FNA (Paragon 28 Corp) - Company Future Revenue|Company Projected Revenue invobioscience.com INVO